logo-loader
FinanceInsurance
Hiscox

Hiscox estimates it faces net claims totalling about US$225mln from both hurricanes Harvey and Irma

The Lloyd's of London underwriter had said on September 18 that Hurricane Harvey alone would cost it at least US$150mln in claims based on an insured market loss of US$25bn

Hurricane
In a statement today, Hiscox said its new estimate was based on an insured market loss of US$35bn for Hurricane Irma

Hiscox Ltd (LON:HSX) has estimated that it would face net claims totalling about US$225mln from both hurricanes Harvey and Irma which battered the Caribbean islands and mainland US in August and September.

The Lloyd's of London underwriter had said on September 18 that Hurricane Harvey alone would cost it at least US$150mln in claims based on an insured market loss of US$25bn.

READ: Hiscox says Harvey devastation will cost it US$150mln

In a statement today, Hiscox said its new estimate was based on an insured market loss of US$35bn for Hurricane Irma.

It added: “Although there is still a degree of uncertainty around these hurricanes, this is within the Group's modelled range of claims for events of this nature, and we still have depth of cover in our reinsurance programme”.

Hurricane Harvey, which lashed the US state of Texas causing flooding was on the scale of Hurricane Sandy in 2012, while Hurricane Irma, was one of the most powerful Atlantic storms on record, which ravaged several islands in the northern Caribbean, before moving onto Florida's Gulf Coast.

READ: Hiscox: JP Morgan Cazenove lowers price target for specialist insurer

Hiscox Group CEO, Bronek Masojada said: These events are already having an impact on rates in the global insurance market, particularly in affected areas and specific sectors. 

“After a number of years of rate reductions, we are starting to see price corrections, most acutely in affected lines such as large property insurance and catastrophe reinsurance, which we expect to spread to non-affected lines.”

Quick facts: Hiscox

Price: £16.01

Market: AIM
Market Cap: £4.62 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

2 days, 6 hours ago

RNS

Director/PDMR Shareholding

1 week, 4 days ago

Total Voting Rights

2 weeks, 2 days ago

Application for Block Listing

2 weeks, 3 days ago

Director/PDMR Shareholding

2 weeks, 3 days ago

Hiscox Ltd interim results

2 weeks, 6 days ago

Trading update

on 07/12/2019

2 min read